Start-Up Previews (07/2007)
A preview of the emerging health care companies profiled in the current, all-profiles issue of Start-Up. This month's profile groups are "Start-Ups in Obesity," "New Technologies for Infertility," and "New Zealand Biotech." Plus these Start-Ups Across Health Care: Intelect Medical, N Spine, and Solace Pharmaceuticals.
You may also be interested in...
GlaxoSmithKline's diabetes drug Avandia survived a perilous FDA advisory committee review. The real question is whether the industry can survive the damage to FDA's credibility.
Solace Pharmaceuticals Inc. is pursuing identification and development of novel pain compounds based on the scientific work of its pedigreed founders. Launched just a little over a year ago, Solace has already taken its first steps for a Phase IIa proof-of-concept trial in neuropathic pain for its lead compound.
With a microfluidics platform designed for cell biology, the founders of Incept BioSystems realized that they had the opportunity to improve the quality of embryos destined for in vitro fertilization. IVF represents a great first market for a small medtech company; and larger markets in cell therapy loom ahead for Incept.